Response to "Reassessing the death risk related to probiotics in critically ill patients".
Publication
, Journal Article
Manzanares, W; Wischmeyer, PE
Published in: Crit Care
February 27, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Crit Care
DOI
EISSN
1466-609X
Publication Date
February 27, 2017
Volume
21
Issue
1
Start / End Page
43
Location
England
Related Subject Headings
- Risk
- Probiotics
- Humans
- Emergency & Critical Care Medicine
- Death
- Critical Illness
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Manzanares, W., & Wischmeyer, P. E. (2017). Response to "Reassessing the death risk related to probiotics in critically ill patients". Crit Care, 21(1), 43. https://doi.org/10.1186/s13054-017-1618-0
Manzanares, William, and Paul E. Wischmeyer. “Response to "Reassessing the death risk related to probiotics in critically ill patients".” Crit Care 21, no. 1 (February 27, 2017): 43. https://doi.org/10.1186/s13054-017-1618-0.
Manzanares W, Wischmeyer PE. Response to "Reassessing the death risk related to probiotics in critically ill patients". Crit Care. 2017 Feb 27;21(1):43.
Manzanares, William, and Paul E. Wischmeyer. “Response to "Reassessing the death risk related to probiotics in critically ill patients".” Crit Care, vol. 21, no. 1, Feb. 2017, p. 43. Pubmed, doi:10.1186/s13054-017-1618-0.
Manzanares W, Wischmeyer PE. Response to "Reassessing the death risk related to probiotics in critically ill patients". Crit Care. 2017 Feb 27;21(1):43.
Published In
Crit Care
DOI
EISSN
1466-609X
Publication Date
February 27, 2017
Volume
21
Issue
1
Start / End Page
43
Location
England
Related Subject Headings
- Risk
- Probiotics
- Humans
- Emergency & Critical Care Medicine
- Death
- Critical Illness
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences